Century Therapeutics, Inc. Quarterly Debt-to-equity in % from Q1 2022 to Q3 2024

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Century Therapeutics, Inc. quarterly Debt-to-equity history and growth rate from Q1 2022 to Q3 2024.
Century Therapeutics, Inc. Debt-to-equity for the quarter ending September 30, 2024 was 94 %, a 38.5% increase year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q3 2024	94	+26.1	+38.5%	Sep 30, 2024
Q2 2024	89.5	+27.8	+45.1%	Jun 30, 2024
Q1 2024	83.7	+27	+47.7%	Mar 31, 2024
Q4 2023	75.7	+24.6	+48.2%	Dec 31, 2023
Q3 2023	67.9	+29.8	+78.1%	Sep 30, 2023
Q2 2023	61.7	+34.4	+126%	Jun 30, 2023
Q1 2023	56.7	+38.6	+213%	Mar 31, 2023
Q4 2022	51.1			Dec 31, 2022
Q3 2022	38.1			Sep 30, 2022
Q2 2022	27.3			Jun 30, 2022
Q1 2022	18.1			Mar 31, 2022

* An asterisk sign (*) next to the value indicates that the value is likely invalid.